RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $209,563 | -69.5% | 1,197,501 | -24.6% | 0.00% | – |
| Q3 2022 | $688,000 | -43.3% | 1,587,927 | +11.3% | 0.00% | – |
| Q2 2022 | $1,213,000 | -93.7% | 1,426,232 | -59.3% | 0.00% | -100.0% |
| Q1 2022 | $19,318,000 | -42.7% | 3,506,569 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $33,705,000 | -45.9% | 3,481,801 | -0.1% | 0.00% | -50.0% |
| Q3 2021 | $62,302,000 | -25.7% | 3,484,480 | +1.4% | 0.00% | 0.0% |
| Q2 2021 | $83,869,000 | -13.0% | 3,435,835 | -5.5% | 0.00% | -33.3% |
| Q1 2021 | $96,397,000 | +291.2% | 3,637,617 | +12.0% | 0.00% | +200.0% |
| Q4 2020 | $24,643,000 | +49.6% | 3,246,723 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $16,470,000 | -17.6% | 3,287,427 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $19,985,000 | +48.8% | 3,342,144 | +10.7% | 0.00% | 0.0% |
| Q1 2020 | $13,431,000 | -54.5% | 3,017,990 | -2.8% | 0.00% | 0.0% |
| Q4 2019 | $29,494,000 | +18.2% | 3,104,641 | -2.3% | 0.00% | 0.0% |
| Q3 2019 | $24,950,000 | -43.2% | 3,178,092 | +13.7% | 0.00% | -50.0% |
| Q2 2019 | $43,961,000 | -8.8% | 2,794,691 | +4.9% | 0.00% | 0.0% |
| Q1 2019 | $48,218,000 | +23.4% | 2,664,050 | +9.6% | 0.00% | 0.0% |
| Q4 2018 | $39,083,000 | +2.4% | 2,430,505 | +52.9% | 0.00% | 0.0% |
| Q3 2018 | $38,155,000 | – | 1,589,798 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |